Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
TC BioPharm (Holdings) PLC Sponsored ADR (TCBPY) Return on Tangible Equity data is not available for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$4.99M |
|
$1.35M |
|
$3.68M |
|
$8.67M |
|
$4.45M |
|
$1.69M |
|
$1.69M |
|
$6.14M |
|
$2.53M |
|
$1.77M |
|
$2.53M |
|
6.23M |
|
| Cash Flow Statement Financials | |
$-6.49M |
|
$-0.04M |
|
$4.69M |
|
$3.11M |
|
$1.27M |
|
$-1.84M |
|
$1.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Tangible Equity |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|